Pasar al contenido principal

PAPEL DE TCFL5 EN PROCESOS DE DIFERENCIACION, INMUNOSENESCENCIA, INFLAMACION Y TRASTORNOS ASOCIADOS AL ENVEJECIMIENTO.

PID2022-137487OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

NIK Is a Mediator of Inflammation and Intimal Hyperplasia in Endothelial Denudation-Induced Vascular Injury

  • Baeza, Ciro
  • Ribagorda, Marta
  • Maya-López, Carla
  • Fresno, Manuel
  • Sánchez-Díaz, Tania
  • Pintor-Chocano, Aránzazu
  • Sanz, Ana Belén
  • Carrasco, Susana
  • Ortiz, Alberto
  • Sánchez-Niño, Maria D.
Neointimal hyperplasia is the main cause of vascular graft failure in the medium term. NFκB is a key mediator of inflammation that is activated during neointimal hyperplasia following endothelial injury. However, the molecular mechanisms involved in NFκB activation are poorly understood. NFκB may be activated through canonical (transient) and non-canonical (persistent) pathways. NFκB-inducing kinase (NIK, MAP3K14) is the upstream kinase of the non-canonical pathway. We have now explored the impact of NIK deficiency on neointimal hyperplasia following guidewire-induced endothelial cell injury and on local inflammation by comparing NIK activity–deficient alymphoplasia mice (NIKaly/aly) with control wild-type (NIK+/+) mice. Guidewire-induced endothelial cell injury caused neointimal hyperplasia and luminal stenosis and upregulated the local expression of NIK and the NFκB target chemokines monocyte chemoattractant protein-1 (MCP-1/CCL2) and chemokine ligand 5 (RANTES/CCL5). Immunohistochemistry disclosed the infiltration of the media and intima by F4/80 positive macrophages. The intima/media ratio and percentage of stenosis were milder in the NIKaly/aly than in the NIK+/+ mice. Additionally, the gene expression for MCP-1 and RANTES was lower and F4/80+ cell infiltration was milder in the NIKaly/aly than in the NIK+/+ mice. Finally, circulating MCP-1 levels were lower in the NIKaly/aly than in the NIK+/+ mice, reflecting milder systemic inflammation. In conclusion, NIK is a driver of vascular wall inflammation and stenosis following guidewire-induced endothelial cell injury. NIK targeting may be a novel therapeutic approach to limit arterial stenosis following endothelial cell injury., We gratefully acknowledge the Agencia Estatal de Investigación (AEI) MICIN (CNS2022-135937), Sociedad Española de Nefrología, Sociedad Madrileña de Nefrología (SOMANE), FRIAT, Comunidad de Madrid en Biomedicina P2022/BMD-7223, CIFRA_COR-CM. Instituto de Salud Carlos III (ISCIII) FIS/Fondos FEDER (PI22/00050, PI21/00251, ERA-PerMed-JTC2022 (SPAREKID AC22/00027), RICORS program to RICORS2040 (RD21/0005/0001) funded by European Union—NextGenerationEU, Mecanismo para la Recuperación y la Resiliencia (MRR) and SPACKDc PMP21/00109, FEDER funds, COST Action PERMEDIK CA21165, supported by COST (European Cooperation in Science and Technology); PREVENTCKD Consortium. Project ID: 101101220 Program: EU4H DG/Agency: HADEA and from “MICIN” (SAF2016-75988-R and PID2022-137487OB-I00) and “Comunidad de Madrid” (S2017/BMD-3671. INFLAMUNE-CM; FEDER) to MF. MDSN was supported by MICINN Ramon y Cajal program RYC2018-024461-I., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Trypanosoma cruzi: Genomic Diversity and Structure

  • Herreros-Cabello, Alfonso
  • Callejas-Hernández, Francisco
  • Gironès, Núria
  • Fresno, Manuel
Trypanosoma cruzi is the causative agent of Chagas disease, a neglected tropical disease, and one of the most important parasitic diseases worldwide. The first genome of T. cruzi was sequenced in 2005, and its complexity made assembly and annotation challenging. Nowadays, new sequencing methods have improved some strains’ genome sequence and annotation, revealing this parasite’s extensive genetic diversity and complexity. In this review, we examine the genetic diversity, the genomic structure, and the principal multi-gene families involved in the pathogenicity of T. cruzi. The T. cruzi genome sequence is divided into two compartments: the core (conserved) and the disruptive (variable in length and multicopy gene families among strains). The disruptive region has also been described as genome plasticity and plays a key role in the parasite survival and infection process. This region comprises several multi-gene families, including trans-sialidases, mucins, and mucin-associated surface proteins (MASPs). Trans-sialidases are the most prevalent genes in the genome with a key role in the infection process, while mucins and MASPs are also significant glycosylated proteins expressed on the parasite surface, essential for its biological functions, as host–parasite interaction, host cell invasion or protection against the host immune system, in both insect and mammalian stages. Collectively, in this review, some of the most recent advances in the structure and composition of the T. cruzi genome are reviewed., This research was funded by “Ministerio de Ciencia e Innovación” (Spain), grant number PID2021-123389OB-I00 and PID2022-137487OB-I00., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Toll-like receptors ligand immunomodulators for the treatment congenital diaphragmatic hernia

  • Vallejo-Cremades, Mayte
  • Merino, Javier
  • Carmona, Rita
  • Córdoba, Laura
  • Salvador, Beatriz
  • Martínez, Leopoldo
  • Tovar, Juan Antonio
  • Llamas, Miguel Ángel
  • Muñoz-Chápuli, Ramón
  • Fresno, Manuel
Background: Congenital diaphragmatic hernia (CDH) is a rare disease that affects the development of the diaphragm, leading to abnormal lung development. Unfortunately, there is no established therapy for CDH. Retinoic acid pathways are implicated in the ethology of CDH and macrophages are known to play a role in repairing organ damage. Methods: We have analyzed the effect of several Toll like receptor (TLR) ligands in the nitrofen-induced CDH model in pregnant rats widely used to study this disease and in the G2-GATA4;Wt1 CDH genetic mice model. Morphometric and histological studies were carried out. Immune cell infiltration was assayed by immunochemistry and immunofluorescence and retinoic pathway gene expression analyzed in vivo and in vitro in macrophages. Results: We found that administering a single dose of atypical TLR2/4 ligands (CS1 or CS2), 3 days after nitrofen, cured diaphragmatic hernia in 73% of the fetuses and repaired the lesion with complete diaphragm closure being on the other hand nontoxic for the mothers or pups. Moreover, these immunomodulators also improved pulmonary hypoplasia and alveolar maturation and vessel hypertrophy, enhancing pulmonary maturity of fetuses. We also found that CS1 treatment rescued the CDH phenotype in the G2-GATA4;Wt1 CDH genetic mice model. Only 1 out of 11 mutant embryos showed CDH after CS1 administration, whereas CDH prevalence was 70% in untreated mutant embryos. Mechanistically, CS1 stimulated the infiltration of repairing M2 macrophages (CD206 and Arg1) into the damaged diaphragm and reduced T cell infiltration. Additionally, those TLR ligands induced retinol pathway genes, including RBP1, RALDH2, RARα, and RARβ, in the affected lungs and the diaphragm and in macrophages in vitro. Conclusions: Our research has shown that TLR ligand immunomodulators that influence anti-inflammatory macrophage activation can be effective in treating CDH, being nontoxic for the mothers or pups suggesting that those TLR ligands are a promising solution for CDH leading to orphan drug designation for CS1. The immune system of the fetus would be responsible for repairing the damage and closure of the hernia in the diaphragm and enhanced proper lung development after CS1 treatment., This research was funded by grants from “Ministerio de Ciencia e Innovación” (SAF2016-75988-R and PID2022-137487OB-I00) and “Comunidad de Madrid” (S2017/BMD-3671. INFLAMUNE-CM; FEDER) to MF, Asociación de la vida con hernia diafragmatica of Spain to MVC and “Ayuda Real e Ilustre Colegio Oficial de Farmacéuticos de Sevilla”, Fundación MEHUER to BS. The study also received institutional grants from “Fundación Ramón Areces” and “Banco de Santander.”
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

RNA Sequence Analysis in Macrophages Infected With Trypanosoma cruzi: Focus on TLR2 and TLR7, Iron Metabolism, and Extracellular Matrix Biosynthesis

  • Callejas-Hernández, Francisco
  • Herreros-Cabello, Alfonso
  • Poveda, Cristina
  • Maza, María C
  • Mares, José Francisco
  • Santos-Peñaloza, Diana K
  • Fresno, Manuel
  • Gironès, Núria
Background. Trypanosoma cruzi is a protozoan parasite responsible for Chagas disease, affecting millions globally. This parasite infects mammalian host cells, particularly macrophages. The interaction between T. cruzi and macrophages involves intricate signaling pathways mediated by pattern recognition receptors, which lead to the production of immune mediators, that are parasite-strain dependent and not completely understood. Methods. We conducted an unbiased transcriptomic analysis of the immune response in mouse macrophages 24 hours postinfection with the Y strain of T. cruzi using RNA-Seq and validated and compared the results using quantitative RT-PCR in macrophages infected with the Y and the VFRA T. cruzi strains. Results. Bioinformatics analysis of the transcriptomics results evidenced a key role of Toll-like receptor 2 (Tlr2) and Tlr7 in the immune response against the parasite that was parasite-dependent. Tlr2 signaling was more activated with the VFRA strain and Tlr7 with the Y strain. Gene ontology analyses predicted a blockage in iron transport mediated by clathrin and the modulation of the extracellular matrix biosynthesis, which were validated by RT-qPCR. Infection with the VFRA strain provoked the inhibition of ferritin, which correlated with parasite proliferation. Conclusions. Our study recapitulates knowledge on the response of macrophages and provides insights into the importance of TLR2 and TLR7, iron metabolism, and extracellular matrix in the infected macrophage, which help the understanding of molecular mechanisms underlying T. cruzi infection in macrophages with strains with different virulence. These findings are crucial for identifying novel therapeutic targets and advancing strategies to combat Chagas disease., This work was supported the Ministerio de Ciencia, Innovación y Universidades-Agencia Estatal de Investigación and Fondo Europeo de Desarrollo Regional (grant numbers PGC2018-096132-B-I00 and PID2021-123389OB-I00 to N. G.); Ministerio de Ciencia e Innovación (grant number PID2022-137487OB-I00 to M. F.); Comunidad de Madrid (grant number S2017/BMD-3671 INFLAMUNE-CM; FEDER to M. F.); Instituto de Salud Carlos III, Red de Investigación Cooperativa en Enfermedades Tropicales (grant number RD16/0027/0006 to M. F.); and institutional grants from Fundación Ramón Areces and Banco de Santander.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Improved identification of T-ALL paediatric patients with low MRD but poor prognosis using a transcriptional signature

  • Lahera, Antonio
  • Vela-Martín, Laura
  • Fernández-Navarro, Pablo
  • López-Lorenzo, José Luis
  • Cornago, Javier
  • Llamas, Pilar
  • Fresno, Manuel
  • Santos, Javier
  • Villa-Morales, María
T-cell acute lymphoblastic leukaemia (T-ALL) is an aggres-sive haematological malignancy that results from the malig-nant transformation of immature thymocytes and exhibitsa heterogeneous molecular landscape.1 Current standard-of-care treatments for T-ALL mainly consist of high-dosemulti-agent chemotherapy and achieve reasonable rates ofinitial complete responses that can reach up to 90% in chil-dren. However, refractory or relapsed patients have a dismalprognosis with survival rates below 10%; hence, most effortsare focused on optimizing first-line treatments and furtherimproving their efficacy. In this context, prognostic mark-ers capable of stratifying patients according to their poten-tial risk are essential, so high-risk patients may benefit frommore intensive chemotherapy regimens or haematopoieticstem cell transplantation, while low-risk patients may bene-fit from less intensive treatment approaches, which are char-acterized by reduced toxicity levels and fewer side effects, Ministerio de Ciencia, Innovación y Universidades, Grant/Award Number: RTI2018-093330-B-I00; Ministerio deEconomía y Competitividad, Grant/Award Number:SAF2015-70561-R; Instituto de Investigación Sanitaria Fundación Jiménez Díaz; Ministerio de Ciencia e Innovación,Grant/Award Number: PID2022-137487OB-I00.